| Literature DB >> 25639323 |
Francesca Pecori Giraldi1, Luigi Maria Cavallo, Fabio Tortora, Rosario Pivonello, Annamaria Colao, Paolo Cappabianca, Franco Mantero.
Abstract
In the management of adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome, inferior petrosal sinus sampling (IPSS) provides information for the endocrinologist, the neurosurgeon, and the neuroradiologist. To the endocrinologist who performs the etiological diagnosis, results of IPSS confirm or exclude the diagnosis of Cushing's disease with 80%-100% sensitivity and over 95% specificity. Baseline central-peripheral gradients have suboptimal accuracy, and stimulation with corticotropin-releasing hormone (CRH), possibly desmopressin, has to be performed. The rationale for the use of IPSS in this context depends on other diagnostic means, taking availability of CRH and reliability of dynamic testing and pituitary imaging into account. As regards the other specialists, the neuroradiologist may collate results of IPSS with findings at imaging, while IPSS may prove useful to the neurosurgeon to chart a surgical course. The present review illustrates the current standpoint of these 3 specialists on the role of IPSS.Entities:
Keywords: ACTH = adrenocorticotropic hormone, or corticotropin; CRH = corticotropin-releasing hormone; Cushing's disease; Cushing's syndrome; IPSS = inferior petrosal sinus sampling; NIH = National Institutes of Health; diagnosis; inferior petrosal sinus sampling; pituitary adenoma; pituitary imaging; pituitary surgery
Mesh:
Substances:
Year: 2015 PMID: 25639323 DOI: 10.3171/2014.11.FOCUS14766
Source DB: PubMed Journal: Neurosurg Focus ISSN: 1092-0684 Impact factor: 4.047